Not every brain aneurysm discovered on imaging requires immediate treatment. This is one of the more counterintuitive aspects of neurovascular care for patients who learn they have an unruptured aneurysm: in many cases, careful observation is a reasonable path forward rather than automatic intervention. The brain aneurysm treatment threshold is not a single fixed number but a judgment that specialists reach by weighing the aneurysm's size, shape, and location against its estimated rupture risk and the patient's overall health. Understanding the general framework behind this decision helps explain why two patients with similarly sized aneurysms might receive different recommendations.
What Factors Influence Whether an Aneurysm Should Be Treated?
Aneurysm size is commonly cited as one of the most significant factors in rupture risk assessment, with larger aneurysms generally associated with a higher estimated risk than smaller ones, though size alone does not fully determine risk. Location also matters, since aneurysms in certain areas of the intracranial circulation have been associated with different rupture risk profiles in published research. Aneurysm shape, including the presence of irregular outpouchings or a daughter sac, is another factor commonly discussed in clinical literature as potentially relevant to risk. Beyond the aneurysm itself, patient-specific factors such as family history of aneurysm or subarachnoid hemorrhage, smoking status, high blood pressure, and age are generally considered as part of the overall risk picture rather than in isolation.
How Does the PHASES Score Fit Into This Decision?
The PHASES score is a tool that has been described in clinical literature as a way to combine several of these factors, including Population, Hypertension, Age, Size of aneurysm, Earlier subarachnoid hemorrhage from another aneurysm, and Site of the aneurysm, into an estimated five-year rupture risk. Tools like this are generally used to support clinical judgment rather than replace it, since they provide a structured way to weigh multiple factors together rather than relying on any single characteristic. Specialists commonly use scoring systems like PHASES alongside a broader clinical evaluation, taking into account the individual patient's health, life expectancy, and personal preferences regarding risk tolerance.
Why Do Some Unruptured Aneurysms Get Treated While Others Are Monitored?
When the estimated rupture risk is considered low relative to the risks associated with treatment itself, specialists may recommend a period of monitoring rather than immediate intervention. Treatment carries its own set of considerations, whether through an endovascular approach or open surgical clipping, and these considerations are weighed against the natural history of leaving a low-risk aneurysm untreated. Conversely, a larger aneurysm, one with irregular features, or one in a higher-risk location may prompt a recommendation for treatment even without symptoms. Patient factors also shape this decision meaningfully: a younger patient with a longer expected lifespan during which rupture risk could accumulate may be approached differently than an older patient with significant other health conditions that raise procedural risk. This is why the brain aneurysm treatment threshold is described as a threshold rather than a rule, since it shifts based on the complete clinical picture rather than a single measurement.
The Role of Endovascular Devices When Treatment Is Recommended
When the decision is made to treat an aneurysm, endovascular approaches such as coiling are among the options a specialist may consider, alongside surgical clipping, depending on the aneurysm's characteristics and the patient's anatomy. The broader category of tools used in these procedures, including devices supporting catheter-based access to the intracranial vasculature, is covered on the INVAMED neurovascular interventions page. A qualified physician determines the appropriate treatment approach, including whether to treat at all, based on a comprehensive evaluation rather than any single risk calculator.
Can an unruptured aneurysm be safely left untreated?
Some unruptured aneurysms with a low estimated rupture risk may be reasonably managed with monitoring rather than immediate treatment, based on individualized assessment. This decision is made by a qualified physician weighing the aneurysm's characteristics against the risks associated with intervention.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.